Medication Errors Could Be Reduced By Randomly Assigning NDC Numbers, FDA Says
Executive Summary
National drug codes should be dissimilar to avoid mistakes by health care providers when they verify they have the right drug, strength and formulation for their patient, FDA says in draft guidance on designing drug container labels and carton labeling.
You may also be interested in...
Container Labels Expose Two Sides Of Color: Attention Getter, Lure To Medication Errors
FDA draft guidance lays out how sponsors can design drug container labels and carton labeling to avoid drug use mistakes by making the most important information accessible to health care providers and patients.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.